Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioNano Genomics, Inc. WT EXP 082123 stock logo
BNGOW
BioNano Genomics, Inc. WT EXP 082123
$0.00
$0.01
$0.00
$0.60
N/AN/A17,799 shs63,789 shs
PEARW
Pear Therapeutics
$0.00
$0.00
$0.90
N/AN/A67,408 shs471,800 shs
VENAW
Venus Acquisition
$0.10
$0.06
$0.01
$0.35
N/AN/A20,861 shsN/A
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioNano Genomics, Inc. WT EXP 082123 stock logo
BNGOW
BioNano Genomics, Inc. WT EXP 082123
0.00%0.00%0.00%0.00%0.00%
PEARW
Pear Therapeutics
0.00%0.00%0.00%0.00%0.00%
VENAW
Venus Acquisition
0.00%0.00%+11.11%+1,328.57%-50.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BioNano Genomics, Inc. WT EXP 082123 stock logo
BNGOW
BioNano Genomics, Inc. WT EXP 082123
N/AN/AN/AN/AN/AN/AN/AN/A
PEARW
Pear Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
VENAW
Venus Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BioNano Genomics, Inc. WT EXP 082123 stock logo
BNGOW
BioNano Genomics, Inc. WT EXP 082123
0.00
N/AN/AN/A
PEARW
Pear Therapeutics
0.00
N/AN/AN/A
VENAW
Venus Acquisition
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BioNano Genomics, Inc. WT EXP 082123 stock logo
BNGOW
BioNano Genomics, Inc. WT EXP 082123
$31.51MN/AN/AN/AN/AN/A
PEARW
Pear Therapeutics
N/AN/AN/AN/AN/AN/A
VENAW
Venus Acquisition
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BioNano Genomics, Inc. WT EXP 082123 stock logo
BNGOW
BioNano Genomics, Inc. WT EXP 082123
N/AN/A0.00N/AN/AN/AN/AN/A
PEARW
Pear Therapeutics
N/AN/A0.00N/AN/AN/AN/AN/AN/A
VENAW
Venus Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BioNano Genomics, Inc. WT EXP 082123 stock logo
BNGOW
BioNano Genomics, Inc. WT EXP 082123
N/AN/AN/AN/AN/A
PEARW
Pear Therapeutics
N/AN/AN/AN/AN/A
VENAW
Venus Acquisition
N/AN/AN/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
BioNano Genomics, Inc. WT EXP 082123 stock logo
BNGOW
BioNano Genomics, Inc. WT EXP 082123
405N/AN/ANot Optionable
PEARW
Pear Therapeutics
N/AN/AN/ANot Optionable
VENAW
Venus Acquisition
N/AN/AN/ANot Optionable

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com
BioNano Genomics, Inc. WT EXP 082123 stock logo

BioNano Genomics, Inc. WT EXP 082123 NASDAQ:BNGOW

at bionano genomics®, we are committed to unlocking understanding of genome biology to advance the promise of genomics in areas including cancer and human disease, agricultural bioengineering and genome discovery. our team is not afraid to venture into uncharted territory to look for answers. we welcome the curious and provide a place where those who are not satisfied with the status quo can feel at home. our next-generation genome mapping and analysis tools help researchers see true genome structure to fill in what's missing from sequencing-based data. saphyr™, our high-speed, high-throughput whole genome mapping solution, offers unmatched structural variation discovery capabilities and the ability to construct the most complete genome assemblies. at bionano, we are invested in the success of our customers and users around the world, and are dedicated to supporting them with the tools, resources and support they need to achieve their goals and make a real impact on improving quality o

Venus Acquisition NASDAQ:VENAW

$0.10 0.00 (0.00%)
As of 05/9/2025